Pretreatment with Group II Metabotropic Glutamate Receptor Agonist LY379268 Protects Neonatal Rat Brains from Oxidative Stress in an Experimental Model of Birth Asphyxia

By Bratek Ewelina   Ziembowicz Apolonia   Salinska Elzbieta  

Brain Sciences, Vol. 8, Iss. 3, 2018-03 ,pp. : 48-48

MDPI

Access to resources Recommend Favorite

Interactions of a Dopamine D₁ Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat

By McMillen Brian A.   Lommatzsch Courtney L.   Sayonh Michael J.   Williams Helen L.  

Pharmaceuticals, Vol. 6, Iss. 4, 2013-03 ,pp. : 469-479

MDPI

Access to resources Recommend Favorite

Classical Transient Receptor Potential 1 (TRPC1): Channel or Channel Regulator?

By Dietrich Alexander   Fahlbusch Meike   Gudermann Thomas  

Cells, Vol. 3, Iss. 4, 2014-09 ,pp. : 939-962

MDPI

Access to resources Recommend Favorite

An integrated view on the role of receptor mosaics at perisynaptic level: focus on adenosine A_2A, dopamine D₂, cannabinoid CB₁, and metabotropic glutamate mGlu₅ receptors

By Agnati Luigi F.   Guidolin Diego   Albertin Giovanna   Trivello Elena   Ciruela Francisco   Genedani Susanna   Tarakanov Alexander   Fuxe Kjell  

Journal of Receptors and Signal Transduction, Vol. 30, Iss. 5, 2010-10 ,pp. : 355-369

Informa Healthcare

Access to resources Recommend Favorite

Anti-Cancer Effect of Metabotropic Glutamate Receptor 1 Inhibition in Human Glioma U87 Cells: Involvement of PI3K/Akt/mTOR Pathway

By  

Cellular Physiology and Biochemistry, Vol. 35, Iss. 2, 2015-01 ,pp. : 419-432

Karger

Access to resources Recommend Favorite